Femasys Share Price

Femasys Share Price

NASDAQ: FEMY | Healthcare
$0.00
-$1.24 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Femasys Stock Performance

Open
N/A
Prev. Close
$1.24
Circuit Range
N/A
Day Range
N/A
Year Range
$0.29 - $6.14
Volume
N/A
Average Traded
N/A

Femasys Share Price Chart

Line chart of the Femasys price trend over the selected period. The price fell overall, ranging from 1.24 to 1.28, ending at 1.24.
$0.00$0.00
L
Show Current Price
H

Femasys Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.51
Revenue (TTM)
$2.29B
Return On Equity (TTM)
-158.11%
Profit Margin
-813.54%
Debt to Equity
0.51
Quarterly Earnings Growth YoY
-15.44%

Femasys Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.81$0.42$0.33$0.40
Net Profit-$3.95$0.33-$4.47-$4.56
Net Profit Margin-487.65%78.57%-1354.55%-1140.00%
Income ChangeN/A108.35%-1454.55%-2.01%

Femasys Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.21$1.07$1.63$2.29
Net Profit-$11.39-$14.25-$18.82-$18.63
Net Profit Margin-941.32%-1331.78%-1154.60%-813.54%
Income ChangeN/A-25.11%-32.07%1.01%

Femasys Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets4.274.424.582.76
Current Assets16.468.0223.1814.13
Total Assets20.7212.4527.7616.9
Non Current Liabilities16.461.566.350.13
Current Liabilities3.648.583.051.53
Total Liabilities20.110.149.41.65
Shareholders' Equity0.622.318.3515.24

Femasys Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-18.69-19.44-11.28-10.73
Investing-0.63-0.85-0.14-0.41
Financing25.142.0320.18-0.68

Corporate Actions

Split
Ex-date: 08 Jun 2026

About Femasys

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Femasys Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.35
$1.24
-9.49%
Oct 2026
$2.18
$1.37
-36.57%
Sep 2026
$3.35
$2.16
-23.27%
Aug 2026
$2.95
$2.81
-4.09%
Jul 2026
$4.28
$2.94
-21.73%
Jun 2026
$0.37
$3.75
+900.00%
May 2026
$0.37
$0.38
+1.90%
Apr 2026
$0.44
$0.37
-12.80%
Mar 2026
$0.55
$0.42
-25.83%
Feb 2026
$0.53
$0.57
+5.18%
Jan 2026
$0.62
$0.54
-5.75%
Dec 2025
$0.95
$0.57
-44.00%

Femasys Share Price FAQs